A detailed history of Mcmillion Capital Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mcmillion Capital Management Inc holds 27,050 shares of BMY stock, worth $1.56 Million. This represents 1.54% of its overall portfolio holdings.

Number of Shares
27,050
Previous 27,320 0.99%
Holding current value
$1.56 Million
Previous $1.89 Million 8.66%
% of portfolio
1.54%
Previous 1.79%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 08, 2023

SELL
$63.71 - $70.74 $17,201 - $19,099
-270 Reduced 0.99%
27,050 $1.73 Million
Q1 2023

Apr 24, 2023

SELL
$65.71 - $74.53 $230,379 - $261,302
-3,506 Reduced 11.37%
27,320 $1.89 Million
Q4 2022

Feb 14, 2023

SELL
$68.48 - $81.09 $60,262 - $71,359
-880 Reduced 2.78%
30,826 $2.22 Million
Q3 2022

Nov 03, 2022

SELL
$0.13 - $76.84 $209 - $123,712
-1,610 Reduced 4.83%
31,706 $2.25 Million
Q2 2022

Aug 03, 2022

SELL
$72.62 - $79.98 $422,430 - $465,243
-5,817 Reduced 14.86%
33,316 $2.57 Million
Q1 2022

Apr 26, 2022

SELL
$61.48 - $73.72 $239,526 - $287,213
-3,896 Reduced 9.05%
39,133 $2.86 Million
Q4 2021

Feb 03, 2022

BUY
$53.63 - $62.52 $5,845 - $6,814
109 Added 0.25%
43,029 $2.68 Million
Q3 2021

Nov 12, 2021

SELL
$59.17 - $69.31 $30,768 - $36,041
-520 Reduced 1.2%
42,920 $2.54 Million
Q2 2021

Jul 30, 2021

SELL
$61.91 - $67.42 $74,292 - $80,904
-1,200 Reduced 2.69%
43,440 $2.9 Million
Q1 2021

May 13, 2021

BUY
$59.34 - $66.74 $33,349 - $37,507
562 Added 1.28%
44,640 $2.82 Million
Q4 2020

Feb 08, 2021

SELL
$57.74 - $65.43 $8,834 - $10,010
-153 Reduced 0.35%
44,078 $2.73 Million
Q3 2020

Nov 10, 2020

SELL
$57.43 - $63.64 $86,719 - $96,096
-1,510 Reduced 3.3%
44,231 $2.67 Million
Q2 2020

Aug 06, 2020

SELL
$54.82 - $64.09 $837,375 - $978,974
-15,275 Reduced 25.03%
45,741 $2.69 Million
Q1 2020

May 22, 2020

SELL
$46.4 - $67.43 $116,139 - $168,777
-2,503 Reduced 3.94%
61,016 $3.4 Million
Q4 2019

Jan 31, 2020

BUY
$49.21 - $64.19 $2,952 - $3,851
60 Added 0.09%
63,519 $4.08 Million
Q3 2019

Nov 12, 2019

SELL
$42.77 - $50.71 $69,501 - $82,403
-1,625 Reduced 2.5%
63,459 $3.22 Million
Q2 2019

Jul 25, 2019

SELL
$44.62 - $49.34 $61,620 - $68,138
-1,381 Reduced 2.08%
65,084 $2.95 Million
Q1 2019

May 09, 2019

BUY
$45.12 - $53.8 $33,930 - $40,457
752 Added 1.14%
66,465 $3.17 Million
Q4 2018

Feb 07, 2019

BUY
$48.76 - $63.23 $50,954 - $66,075
1,045 Added 1.62%
65,713 $3.42 Million
Q3 2018

Nov 01, 2018

BUY
$55.19 - $62.25 $34,438 - $38,844
624 Added 0.97%
64,668 $4.02 Million
Q2 2018

Aug 06, 2018

BUY
$50.53 - $62.98 $45,628 - $56,870
903 Added 1.43%
64,044 $3.54 Million
Q1 2018

Apr 30, 2018

BUY
$59.92 - $68.98 $9,587 - $11,036
160 Added 0.25%
63,141 $3.99 Million
Q4 2017

Feb 06, 2018

BUY
$59.94 - $65.35 $48,551 - $52,933
810 Added 1.3%
62,981 $3.86 Million
Q3 2017

Nov 20, 2017

SELL
$55.23 - $63.74 $38,108 - $43,980
-690 Reduced 1.1%
62,171 $3.96 Million
Q2 2017

Aug 09, 2017

BUY
N/A
62,861
62,861 $3.5 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Mcmillion Capital Management Inc Portfolio

Follow Mcmillion Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcmillion Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mcmillion Capital Management Inc with notifications on news.